Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Lipocine Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q3 2021
- Shares held
- 10.6M
- +1.43M (+15.6%) vs. Q3 2021
- Total value
- $10.5M
- +$506.9K (+5.1%) vs. Q3 2021
- New holders
- 8
- 8 more added
- Sold out
- 7
- 12 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,809,970 | $3.78M | 0.00% | −5,378−0.1% | Reduced |
| BlackRock Inc. | 1,594,547 | $1.58M | 0.00% | +14,029+0.9% | Added |
| Wealth Effects LLC | 1,489,434 | $1.48M | 0.61% | +1,489,434 | New |
| Geode Capital Management, LLC | 824,434 | $817.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 440,432 | $437.0K | 0.05% | +125,124+39.7% | Added |
| Mercer Global Advisors Inc | 313,111 | $310.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 304,617 | $302.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 240,300 | $238.0K | 0.00% | −9,118−3.7% | Reduced |
| Morgan Stanley | 226,248 | $224.0K | 0.00% | −194,970−46.3% | Reduced |
| Price T Rowe Associates Inc | 184,662 | $183.0K | 0.00% | +4,798+2.7% | Added |
| Northern Trust Corp | 168,225 | $167.0K | 0.00% | −346−0.2% | Reduced |
| Susquehanna International Group, LLP | 164,977 | $163.0K | 0.00% | +125,280+315.6% | Added |
| Virtu Financial LLC | 117,486 | $116.0K | 0.01% | +87,417+290.7% | Added |
| Two Sigma Investments, LP | 102,600 | $102.0K | 0.00% | +102,600 | New |
| MML Investors Services, LLC | 77,000 | $76.0K | 0.00% | +25,000+48.1% | Added |
| Ameriprise Financial Inc | 66,500 | $66.0K | 0.00% | −339,500−83.6% | Reduced |
| RSM US Wealth Management LLC | 65,212 | $65.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 62,750 | $62.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 55,204 | $55.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 53,000 | $53.0K | 0.00% | +53,000 | New |
| Charles Schwab Investment Management Inc | 50,000 | $50.0K | 0.00% | +50,000 | New |
| Citadel Advisors LLC | 35,605 | $36.0K | 0.00% | −20,015−36.0% | Reduced |
| HRT Financial LP | 24,180 | $23.0K | 0.00% | +24,180 | New |
| Jane Street Group, LLC | 22,638 | $22.0K | 0.00% | −14,844−39.6% | Reduced |
| Moloney Securities Asset Management, LLC | 22,500 | $22.0K | 0.00% | −7,500−25.0% | Reduced |
| Plante Moran Financial Advisors, LLC | 17,000 | $17.0K | 0.00% | +17,000 | New |
| Pinnacle Private Wealth, LLC | 15,250 | $15.0K | 0.00% | +15,250 | New |
| Goldman Sachs Group Inc | 14,187 | $14.0K | 0.00% | +14,187 | New |
| ExodusPoint Capital Management, LP | 11,715 | $12.0K | 0.00% | −10,952−48.3% | Reduced |
| Cutler Group LP | 13,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 4,112 | $5.00K | 0.00% | +10.0% | Added |
| UBS Group AG | 4,000 | $4.00K | 0.00% | +1,926+92.9% | Added |
| Tower Research Capital LLC (TRC) | 2,559 | $3.00K | 0.00% | −5,009−66.2% | Reduced |
| JPMorgan Chase & Co | 3,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,500 | $1.00K | 0.00% | −14,800−90.8% | Reduced |
| Bank of America Corp | 1,167 | $1.00K | 0.00% | −989−45.9% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 186 | $0 | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 0 | $0 | 0.00% | −28,762−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −24,075−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −24,075−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −17,539−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Global Wealth Management Investment Advisory, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Prentice Wealth Management LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |